According to the latest data from the Hong Kong Stock Exchange, on December 31, Board Chairman Wu Yifang increased his holdings in Everest Med (01952) by 30,000 shares. The transaction was executed at a price of HK$37.98 per share, amounting to a total value of HK$1,139,400.
Following this purchase, his total shareholding has risen to approximately 2.0747 million shares, which represents a 0.59% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments